You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
信立泰(002294.SZ)獲鹽酸樂卡地平片藥品註冊批件
格隆匯 06-22 21:06

格隆匯 6 月 22日丨信立泰(002294.SZ)公佈,近日,公司收到國家藥品監督管理局核准簽發的鹽酸樂卡地平片《藥品註冊批件》。

“鹽酸樂卡地平”適用於治療輕、中度原發性高血壓,為第三代二氫吡啶類鈣通道阻滯劑,對血管平滑肌具有較強選擇性,較少影響心臟,具有降壓作用持久、不良反應發生率低等優勢,為《國家基本醫療保險、工傷保險和生育保險藥品目錄》醫保乙類產品。

公司的鹽酸樂卡地平為國內首家按照一致性評價的要求完成生物等效性試驗,並視同通過一致性評價。該產品的上市,將進一步豐富公司在心腦血管領域的產品線,為患者提供更多用藥選擇,強化公司在心腦血管產業鏈的優勢地位。

鹽酸樂卡地平的上市,對公司今後的業績提升和長遠發展將產生積極的影響。但具體銷售情況將受市場環境變化等因素的影響,存在一定的不確定性,敬請廣大投資者理性投資,注意風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account